[SCHEDULE 13G/A] Edwards Lifesciences Corp SEC Filing
Wellington Management reports beneficial ownership of 19,826,483 shares of Edwards Lifesciences common stock, equal to 3.38% of the class. The filing shows shared voting power of 18,601,111 shares and shared dispositive power of 19,826,483 shares, while sole voting and dispositive power are reported as zero. The securities are owned of record by clients of Wellington investment advisers.
The filing names the reporting entities (Wellington Management Group LLP; Wellington Group Holdings LLP; Wellington Investment Advisors Holdings LLP) and lists the Wellington investment advisers that control the client accounts. It also includes a certification that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Wellington Management segnala la propriet脿 beneficiaria di 19,826,483 azioni ordinarie di Edwards Lifesciences, pari al 3.38% della classe. La comunicazione indica un potere di voto condiviso su 18,601,111 azioni e un potere di disposizione condiviso su 19,826,483 azioni; il potere di voto e il potere di disposizione in forma esclusiva sono riportati a zero. I titoli risultano registrati a nome di clienti dei gestori di investimento di Wellington.
La segnalazione nomina le entit脿 dichiarante (Wellington Management Group LLP; Wellington Group Holdings LLP; Wellington Investment Advisors Holdings LLP) e elenca i gestori d'investimento Wellington che controllano i conti dei clienti. Include inoltre una certificazione che le azioni sono state acquisite e vengono detenute nell'ordinario svolgimento dell'attivit脿 commerciale e non con l'intento di modificare o influenzare il controllo dell'emittente.
Wellington Management informa de la titularidad beneficiaria de 19,826,483 acciones ordinarias de Edwards Lifesciences, equivalentes al 3.38% de la clase. La presentaci贸n muestra poder de voto compartido sobre 18,601,111 acciones y poder dispositvo compartido sobre 19,826,483 acciones, mientras que el poder de voto y el poder dispositvo en forma individual figuran en cero. Los valores est谩n registrados a nombre de clientes de los asesores de inversi贸n de Wellington.
El informe nombra a las entidades informantes (Wellington Management Group LLP; Wellington Group Holdings LLP; Wellington Investment Advisors Holdings LLP) y enumera los asesores de inversi贸n de Wellington que controlan las cuentas de los clientes. Tambi茅n incluye una certificaci贸n de que las acciones fueron adquiridas y se mantienen en el curso ordinario del negocio y no con el prop贸sito de cambiar o influir en el control del emisor.
Wellington Management電� Edwards Lifesciences 氤错喌欤� 19,826,483欤检棎 雽�頃� 鞁れ鞝� 靻岇湢毳� 鞁犼碃頄堨溂氅�, 鞚措姅 頃措嫻 膦呺鞚� 3.38%鞐� 頃措嫻頃╇媹雼�. 鞝滌稖 靹滊鞐愲姅 18,601,111欤检棎 雽�頃� 瓿惦彊 鞚橁舶甓�瓿� 19,826,483欤检棎 雽�頃� 瓿惦彊 觳橂秳甓�鞚� 旮办灛霅橃柎 鞛堦碃, 雼弲 鞚橁舶甓� 氚� 雼弲 觳橂秳甓岇潃 0鞙茧 氤搓碃霅橃柎 鞛堨姷雼堧嫟. 鞚� 歃濌秾霌れ潃 鞗半韯� 韴瀽鞛愲靷潣 瓿犼皾 氇呾潣搿� 霌膘灛霅橃柎 鞛堨姷雼堧嫟.
鞁犼碃靹滌棎電� 氤搓碃 氩曥澑霌�(Wellington Management Group LLP; Wellington Group Holdings LLP; Wellington Investment Advisors Holdings LLP)鞚� 氇呾嫓霅橃柎 鞛堨溂氅�, 瓿犼皾 瓿勳毳� 甏�毽晿電� 鞗半韯� 韴瀽鞛愲靷摛鞚� 鞐搓卑霅橃柎 鞛堨姷雼堧嫟. 霕愴暅 頃措嫻 欤检嫕鞚� 韱奠儊鞝侅澑 鞓侅梾 瓿检爼鞐愳劀 旆摑路氤挫湢霅� 瓴冹澊氅� 氚滍枆靷潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞚挫棎 鞓來枼鞚� 氙胳範 氇╈爜鞚� 鞎勲嫎鞚� 頇曥澑頃橂姅 鞚胳靹滉皜 韽暔霅橃柎 鞛堨姷雼堧嫟.
Wellington Management d茅clare la propri茅t茅 b茅n茅ficiaire de 19,826,483 actions ordinaires d'Edwards Lifesciences, soit 3.38% de la classe. Le d茅p么t indique un pouvoir de vote partag茅 sur 18,601,111 actions et un pouvoir de disposition partag茅 sur 19,826,483 actions, tandis que les pouvoirs de vote et de disposition exclusifs sont d茅clar茅s 脿 z茅ro. Les titres sont enregistr茅s au nom de clients des conseillers en investissement de Wellington.
Le dossier identifie les entit茅s d茅clarantes (Wellington Management Group LLP; Wellington Group Holdings LLP; Wellington Investment Advisors Holdings LLP) et 茅num猫re les conseillers en investissement de Wellington qui contr么lent les comptes clients. Il comprend 茅galement une attestation que les actions ont 茅t茅 acquises et sont d茅tenues dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le de l'茅metteur.
Wellington Management meldet wirtschaftliches Eigentum an 19,826,483 Stammaktien von Edwards Lifesciences, entsprechend 3.38% der Klasse. Die Einreichung weist ein gemeinsames Stimmrecht f眉r 18,601,111 Aktien und eine gemeinsame Verf眉gungsbefugnis f眉r 19,826,483 Aktien aus; alleinige Stimm- und Verf眉gungsbefugnisse werden mit null angegeben. Die Wertpapiere sind im Register auf Kunden der Anlageberater von Wellington eingetragen.
Die Meldung benennt die berichtspflichtigen Einheiten (Wellington Management Group LLP; Wellington Group Holdings LLP; Wellington Investment Advisors Holdings LLP) und listet die Wellington-Anlageberater auf, die die Kundenkonten steuern. Sie enth盲lt zudem eine Best盲tigung, dass die Aktien im gew枚hnlichen Gesch盲ftsverkehr erworben und gehalten werden und nicht zum Zweck der 脛nderung oder Beeinflussung der Kontrolle 眉ber den Emittenten dienen.
- Aggregated beneficial ownership disclosed: 19,826,483 shares (3.38%)
- Clear governance of holdings: shared voting power (18,601,111) and shared dispositive power documented
- Held in ordinary course: filing certifies shares are not held to influence control of the issuer
- None.
Insights
TL;DR: A sizable passive stake disclosed: 19.83M EW shares (3.38%), held in client accounts with shared voting influence.
The Schedule 13G/A reports aggregated beneficial ownership of 19,826,483 Edwards Lifesciences shares, representing 3.38% of the class, with 18,601,111 shares carrying shared voting power. This indicates the holdings are material enough to warrant disclosure but remain below the 5% threshold that often triggers additional investor-level identification. The filing clarifies ownership is of record by clients of Wellington advisers and includes the statutory certification that the positions are held in the ordinary course of business and not for control purposes, consistent with passive investor treatment.
TL;DR: Disclosure is routine and indicates shared control through client mandates, not an active control campaign.
The filing identifies Wellington entities as the reporting parties and lists the specific investment adviser affiliates that manage the client accounts. Reported shared voting and dispositive powers show Wellington exercises influence on behalf of clients rather than sole control. The certification in the filing confirms the positions were not acquired to influence issuer control, which aligns with a passive Schedule 13G disclosure rather than an activist intent.
Wellington Management segnala la propriet脿 beneficiaria di 19,826,483 azioni ordinarie di Edwards Lifesciences, pari al 3.38% della classe. La comunicazione indica un potere di voto condiviso su 18,601,111 azioni e un potere di disposizione condiviso su 19,826,483 azioni; il potere di voto e il potere di disposizione in forma esclusiva sono riportati a zero. I titoli risultano registrati a nome di clienti dei gestori di investimento di Wellington.
La segnalazione nomina le entit脿 dichiarante (Wellington Management Group LLP; Wellington Group Holdings LLP; Wellington Investment Advisors Holdings LLP) e elenca i gestori d'investimento Wellington che controllano i conti dei clienti. Include inoltre una certificazione che le azioni sono state acquisite e vengono detenute nell'ordinario svolgimento dell'attivit脿 commerciale e non con l'intento di modificare o influenzare il controllo dell'emittente.
Wellington Management informa de la titularidad beneficiaria de 19,826,483 acciones ordinarias de Edwards Lifesciences, equivalentes al 3.38% de la clase. La presentaci贸n muestra poder de voto compartido sobre 18,601,111 acciones y poder dispositvo compartido sobre 19,826,483 acciones, mientras que el poder de voto y el poder dispositvo en forma individual figuran en cero. Los valores est谩n registrados a nombre de clientes de los asesores de inversi贸n de Wellington.
El informe nombra a las entidades informantes (Wellington Management Group LLP; Wellington Group Holdings LLP; Wellington Investment Advisors Holdings LLP) y enumera los asesores de inversi贸n de Wellington que controlan las cuentas de los clientes. Tambi茅n incluye una certificaci贸n de que las acciones fueron adquiridas y se mantienen en el curso ordinario del negocio y no con el prop贸sito de cambiar o influir en el control del emisor.
Wellington Management電� Edwards Lifesciences 氤错喌欤� 19,826,483欤检棎 雽�頃� 鞁れ鞝� 靻岇湢毳� 鞁犼碃頄堨溂氅�, 鞚措姅 頃措嫻 膦呺鞚� 3.38%鞐� 頃措嫻頃╇媹雼�. 鞝滌稖 靹滊鞐愲姅 18,601,111欤检棎 雽�頃� 瓿惦彊 鞚橁舶甓�瓿� 19,826,483欤检棎 雽�頃� 瓿惦彊 觳橂秳甓�鞚� 旮办灛霅橃柎 鞛堦碃, 雼弲 鞚橁舶甓� 氚� 雼弲 觳橂秳甓岇潃 0鞙茧 氤搓碃霅橃柎 鞛堨姷雼堧嫟. 鞚� 歃濌秾霌れ潃 鞗半韯� 韴瀽鞛愲靷潣 瓿犼皾 氇呾潣搿� 霌膘灛霅橃柎 鞛堨姷雼堧嫟.
鞁犼碃靹滌棎電� 氤搓碃 氩曥澑霌�(Wellington Management Group LLP; Wellington Group Holdings LLP; Wellington Investment Advisors Holdings LLP)鞚� 氇呾嫓霅橃柎 鞛堨溂氅�, 瓿犼皾 瓿勳毳� 甏�毽晿電� 鞗半韯� 韴瀽鞛愲靷摛鞚� 鞐搓卑霅橃柎 鞛堨姷雼堧嫟. 霕愴暅 頃措嫻 欤检嫕鞚� 韱奠儊鞝侅澑 鞓侅梾 瓿检爼鞐愳劀 旆摑路氤挫湢霅� 瓴冹澊氅� 氚滍枆靷潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞚挫棎 鞓來枼鞚� 氙胳範 氇╈爜鞚� 鞎勲嫎鞚� 頇曥澑頃橂姅 鞚胳靹滉皜 韽暔霅橃柎 鞛堨姷雼堧嫟.
Wellington Management d茅clare la propri茅t茅 b茅n茅ficiaire de 19,826,483 actions ordinaires d'Edwards Lifesciences, soit 3.38% de la classe. Le d茅p么t indique un pouvoir de vote partag茅 sur 18,601,111 actions et un pouvoir de disposition partag茅 sur 19,826,483 actions, tandis que les pouvoirs de vote et de disposition exclusifs sont d茅clar茅s 脿 z茅ro. Les titres sont enregistr茅s au nom de clients des conseillers en investissement de Wellington.
Le dossier identifie les entit茅s d茅clarantes (Wellington Management Group LLP; Wellington Group Holdings LLP; Wellington Investment Advisors Holdings LLP) et 茅num猫re les conseillers en investissement de Wellington qui contr么lent les comptes clients. Il comprend 茅galement une attestation que les actions ont 茅t茅 acquises et sont d茅tenues dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le de l'茅metteur.
Wellington Management meldet wirtschaftliches Eigentum an 19,826,483 Stammaktien von Edwards Lifesciences, entsprechend 3.38% der Klasse. Die Einreichung weist ein gemeinsames Stimmrecht f眉r 18,601,111 Aktien und eine gemeinsame Verf眉gungsbefugnis f眉r 19,826,483 Aktien aus; alleinige Stimm- und Verf眉gungsbefugnisse werden mit null angegeben. Die Wertpapiere sind im Register auf Kunden der Anlageberater von Wellington eingetragen.
Die Meldung benennt die berichtspflichtigen Einheiten (Wellington Management Group LLP; Wellington Group Holdings LLP; Wellington Investment Advisors Holdings LLP) und listet die Wellington-Anlageberater auf, die die Kundenkonten steuern. Sie enth盲lt zudem eine Best盲tigung, dass die Aktien im gew枚hnlichen Gesch盲ftsverkehr erworben und gehalten werden und nicht zum Zweck der 脛nderung oder Beeinflussung der Kontrolle 眉ber den Emittenten dienen.
FAQ
How many Edwards Lifesciences (EW) shares does Wellington report owning?
What percentage of EW does the reported stake represent?
Does Wellington have sole voting or dispositive power over these EW shares?
Are the EW shares held for clients or by Wellington itself?
Was the stake acquired to influence control of Edwards Lifesciences?
